The potential role of quorum-sensing peptides in oncology

E Wynendaele1, E Pauwels, C Van de Wiele

  • 1Drug Quality and Registration (DruQuaR) Group, Faculty of Pharmaceutical Sciences, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium.

Medical Hypotheses
|April 20, 2012
PubMed

Insights

Quorum-sensing peptides, used in bacteria, show potential for cancer therapy. This novel approach could expand peptide drug development for oncology, offering new treatment avenues.

Area of Science:

  • Oncology
  • Microbiology
  • Drug Discovery

Background:

  • Cancer remains a leading global cause of death, necessitating innovative treatment strategies.
  • Current oncology research explores peptide drugs, with 15 already approved for cancer therapy.
  • Late diagnosis and limited cures for some cancers highlight the need for new therapeutic paradigms.

Purpose of the Study:

  • To propose quorum-sensing peptide agonists and antagonists as a novel therapeutic strategy in oncology.
  • To explore the potential of quorum-sensing peptides to expand the available peptide drug space for cancer treatment.

Main Methods:

  • Reviewing evidence of prokaryote-eukaryote signaling via quorum-sensing molecules.
  • Comparing bacterial quorum-sensing mechanisms with tumor cell metastasis.
  • Analyzing the potential for multiple receptor targeting and pharmacologic manipulation of peptides.

Main Results:

  • The study hypothesizes that quorum-sensing peptides can be leveraged in oncology.
  • Identified similarities between bacterial quorum sensing and cancer cell metastasis.
  • Highlighted the potential for enhanced receptor targeting through peptide manipulation.

Conclusions:

  • Quorum-sensing peptides represent a largely unexplored area in oncology.
  • This approach offers a promising avenue for developing novel cancer therapeutics.
  • Further investigation into quorum-sensing peptides is warranted for their potential in cancer treatment.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...